EPO Quality Of Life Claims Unsubstantiated, FDA Says, May Be Cut From Label
Executive Summary
FDA is considering deleting patient-reported outcomes claims from epoetin alfa labeling, the agency announced during an advisory committee review of the anemia drug
You may also be interested in...
Patient-reported Outcome Claims On Kepivance Site Gets Full Throated FDA Response
SOBi’s oral mucositis treatment was studied in controlled trials that used patient-reported outcome measures, but their content validity has not been established, FDA’s Office of Prescription Drug Promotion says.
Industry Collaboration Targets Patient-Reported Outcomes Tools In Cancer
Industry efforts to collaborate on drug development issues have moved into the arena of patient-reported outcomes, with a consortium forming to improve ways patients report cancer-related fatigue
Industry Collaboration Targets Patient-Reported Outcomes Tools In Cancer
Industry efforts to collaborate on drug development issues have moved into the arena of patient-reported outcomes, with a consortium forming to improve ways patients report cancer-related fatigue